Dr. Paul J. Camarata, MD

Dr. Camarata practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Camarata's NPI, 1558398982, was assigned on June 28, 2006. Dr. Camarata graduated from University of Kansas School of Medicine - Kansas City in 1986. Dr. Camarata's Kansas license number on file is 04-26166.

Dr. Camarata's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Camarata's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Camarata to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Camarata practices, 2 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Camarata's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Camarata is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Camarata's licenses on file in 4 states: Kansas, Missouri, New Mexico and Minnesota.

Dmand AI lists craniotomy and lower back pain among the conditions Dr. Camarata treats.

CMS data shows 139 Medicare services from Dr. Camarata across 4 procedure codes in 2024, all of them office visits, for 140 Medicare patients. Medicare paid $7,711 for them.

CMS counts 140 Medicare patients who saw Dr. Camarata in 2024. The largest group is 65 to 74, with 68 patients. 73% of them have high blood pressure, and 71% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Camarata's median patient age at 70, with 78% women.

In 2024, Dr. Camarata wrote 38 Medicare Part D claims for 21 patients. 97% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $272 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Camarata for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 64 papers to Dr. Camarata, published from 2011 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Cerebral Hemorrhage, Minimally Invasive Surgical Procedures and Brain Ischemia. Dr. Camarata has published most often in Neurosurgery. Dr. Camarata's most frequent co-authors are Issam A. Awad, Roberto Cosme Heros, MD and Mark R. Harrigan.

Dmand AI links Dr. Camarata to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Cerebral Hemorrhage and Intracranial Hemorrhages. Johns Hopkins University sponsors the most, 2.

CMS Open Payments shows 19 general payments to Dr. Camarata from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 68% of the total. Zimmer Biomet Holdings, Inc. paid the most, $1,061.

Dmand AI lists 6 awards for Dr. Camarata, most recently Regional Top Doctor in 2014.

Dr. Camarata graduated from University of Kansas School of Medicine - Kansas City in 1986. Dr. Camarata is a member of AANS, ACS, CNS and North American Skull Base Society.

Dr. Camarata is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.